Introduction
============

Endothelial dysfunction precedes hypertension and atherosclerosis[@b1-vhrm-7-541],[@b2-vhrm-7-541] and is a prognostic indicator of future cardiovascular events. In response to sensing hormonal, biochemical, and mechanical stimuli, the endothelium releases mediators of vascular function, initiates inflammatory processes, and influences homeostasis. In the US, African Americans experience higher mortality from cardiovascular disease (CVD) including hypertension compared to Caucasians or Mexican Americans.[@b3-vhrm-7-541]

An impaired endothelium is conventionally thought to be analogous to diminished nitric oxide (NO)-mediated vasodilation in response to endothelial NO synthase (eNOS) agonists such as acetylcholine or bradykinin. Currently, there is an expanded appreciation of endothelial dysfunction which includes a proinflammatory, pro-oxidant, and prothrombic EC state. Several studies have shown that African-Americans have impaired endothelial function as determined by flow-mediated dilation (FMD)[@b4-vhrm-7-541]--[@b6-vhrm-7-541] and other measures of endothelial-dependent vasodilation.[@b7-vhrm-7-541]--[@b12-vhrm-7-541]

The mechanisms underlying racial disparities in CVD and endothelial dysfunction are multifactorial, but could be due, in part, to differences in endothelial cell (EC) responses to stimuli. However, a major problem with research on the racial disparity in endothelial dysfunction is that it is conducted at the organ or clinical levels and not at the cellular level. This lack of knowledge about the EC biology of African Americans severely impedes advances in finding optimal preventive and treatment strategies.

In response to proinflammatory cytokine stimulation, ECs undergo functional changes that include increased expression/production of IL-6 and adhesion molecules, and induction of procoagulant activity.[@b13-vhrm-7-541]--[@b15-vhrm-7-541] African Americans have also been shown to have higher levels of inflammatory markers compared to Caucasians and this also may contribute to the greater CVD-related morbidity and mortality in this population.[@b16-vhrm-7-541]--[@b21-vhrm-7-541] Studies have linked inflammation to EC activation, an early step in endothelial dysfunction, and loss of NO bioactivity.[@b22-vhrm-7-541] In a cell culture study, Kalinowski et al showed that human umbilical ECs (HUVECs) from African Americans had reduced NO bioavailability compared to Caucasian HUVECs primarily due to increased superoxide (O~2~^−^) production and eNOS uncoupling.[@b23-vhrm-7-541]

Endothelial microparticles (EMP) are submicroscopic membranous particles that are released from activated or apoptotic parent EC when stimulated by proinflammatory cytokines, oxidative stress, or infectious agents.[@b24-vhrm-7-541] They carry with them a subset of membrane proteins and phospholipids, or markers, of their parent EC including those induced by activation, apoptosis or oxidative stress. Recent evidence indicates that EMPs provide valuable information about the biological status of the endothelium. Previous studies have shown that EMPs expressing constitutive surface markers such as CD31 (platelet endothelial cell adhesion molecule; PECAM) are increased in injury and/or apoptosis.[@b25-vhrm-7-541] Results from both clinical and laboratory studies demonstrate that higher EMP levels are related to diminished endothelium-dependent vasodilation. The level of EMP appears to correlate with the degree of endothelial dysfunction in patients with chronic renal failure[@b26-vhrm-7-541] or coronary artery disease.[@b27-vhrm-7-541] Thus, the level of EMPs is emerging as a novel direct marker of EC impairment mediated by activation and apoptosis[@b28-vhrm-7-541],[@b29-vhrm-7-541] and may provide new insight into the mechanisms of racial disparities in endothelial dysfunction. However, EMPs have never been used to assess potential racial differences in endothelial function.

Due to the hypothesized mechanisms leading to endothelial dysfunction and EC impairment in African Americans, the purpose of our study was to observe EMP responses to inflammatory cytokine (TNF-α) and antioxidant ( superoxide dismutase, SOD) conditions in HUVECs obtained from African Americans and Caucasians.

Methods
=======

Human umbilical vein endothelial cells
--------------------------------------

HUVECs were purchased from Lonza Inc (Walkersville, MD), who harvested ECs from umbilical cord donors (AA, n = 3; Caucasian, n = 3). Cryopreserved HUVECs were then shipped by Lonza as frozen primaries. The HUVECs were cultured in parallel, in EGM medium supplemented with 2% fetal bovine serum (FBS) and growth factors (Lonza, Inc) at 37°C in a 95% air −5% CO~2~ atmosphere, following methods by Lonza. All Lonza HUVECs are characterized by morphological observation through serial passaging, positive test for von Willebrand Factor VIII and acetylated low density lipoprotein (LDL) uptake, and negative test for α-smooth muscle actin.

Experimental procedures
-----------------------

Human recombinant TNF-α was purchased from Sigma (St Louis, MO) and SOD was purchased from Worthington Biochemical Corporation (Lakewood, NJ). Parallel HUVEC cultures were tested under four separate conditions: Control, TNF-α (100 U/mL) for 4 hours, SOD (100 U/mL) for 24 hours, and TNF-α + SOD. 100 U/mL of TNF-α was selected because it is a typical level used to stimulate ECs and falls approximately midway between the highest and lowest levels used to stimulate ECs in similar studies.[@b30-vhrm-7-541]--[@b35-vhrm-7-541] Culture media samples (4 mL) obtained from 10^6^ ECs were collected and immediately frozen at −80°C for subsequent EMP analysis.[@b25-vhrm-7-541],[@b36-vhrm-7-541] Remaining culture supernatant was collected for IL-6 assay.

Cell lysate was collected by cellular fractionation for total SOD activity measurements. Briefly, cells were washed once with ice-cold phosphate buffer solution, and resuspended in 2 mL cold 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (Lonza) using a rubber scraper. Cells were centrifuged at 600*g* for 10 minutes at 4°C. The cell pellet was resuspended in 500 μL cold HEPES buffer and then transferred to a Teflon glass homogenizer. The cell solution was homogenized at 1600 rpm for 30 strokes while on ice, and then immediately centrifuged at 1500*g* for 5 minutes at 4°C. Protein concentration was measured using the Bradford method.

For all procedures, AA and Caucasian HUVECs at passage 4 were treated identically. For assay, experimental samples were tested in duplicate and control samples of culture media were tested along with the cell samples in order to eliminate potential interference from culture media in measurements. Absorbance was read using a SpectraMax Microplate Reader (Molecular Devices, Sunnyvale, CA).

EMP immunolabeling
------------------

Microparticles express several different cell surface markers which can be quantified. The preferred method is the 2-color combination of phycoerythrin (PE)-labeled anti-CD31 with fluorescein isothiocyanate (FITC)-labeled anti-CD42. Because CD31 is also found on platelets, platelet-specific CD42 allows counting the platelet microparticles population (CD31+, CD42+) distinct from EMP (CD31+, CD42−), giving both counts in a single run. This pair of markers has the advantage of being very bright and therefore sensitive.[@b29-vhrm-7-541] EMP samples were prepared as previously described.[@b37-vhrm-7-541],[@b38-vhrm-7-541]

To remove unwanted cellular fragments, thawed culture media (1.5 mL) was centrifuged for 5 minutes at 4300*g* (20°C). Supernatant was removed and transferred into a new tube and centrifuged for 90 minutes at 3152*g* (20°C). 100 μL of the supernatant was transferred to a new tube and incubated with 20 μL of anti-human CD31+ (PE) and 20 μL of anti CD42 (FITC) in the dark at room temperature (30 minutes), then fixed by adding 93 μL of 10% formaldehyde. The mixture was protected from light and incubated while being gently mixed for 20 minutes using a shaker. Samples were diluted in 500 μL of double-filtered (0.22 μm) PBS for a total sample volume of 733 μL. Two additional tubes were prepared to serve as a negative control and as a calibration. For the negative control tube, 733 μL of PBS was added to one tube. To prepare the calibrator sample, two drops of 0.9 μm standard precision NIST traceable polystyrene particle beads ( Polysciences Inc, Warrington PA) were added to PBS according to the manufacturer's instructions. All samples were then immediately analyzed by flow cytometry.

Flow cytometry
--------------

Labeled EMP produced by 10^6^ ECs were analyzed using an LSRII flow cytometer (BD Biosciences, San Jose, CA) and analyzed with BD FACSDiva software (v 1.2.6; BD Biosciences). There is no consensus on the threshold level setting which determines the smallest size microparticle analyzed, therefore we set the threshold levels based on the number of background events per second when double-filtered PBS was passed through the flow cytometer as reported by Orozco and Lewis.[@b39-vhrm-7-541] The upper limit of gate was determined by 0.9 μm standard beads. CD31+/ C42− events included in this gate were identified in forward and side scatter intensity dot representation and plotted on 2-color fluorescence histograms and were considered EMP.[@b5-vhrm-7-541],[@b40-vhrm-7-541],[@b41-vhrm-7-541]--[@b43-vhrm-7-541] From each 50 μL sample, the percentage of EMP from 50,000 total events was recorded.[@b40-vhrm-7-541],[@b41-vhrm-7-541] Before every run, the machine was kept running until the background events fell to baseline levels. The final EMP values were then expressed as % total events[@b40-vhrm-7-541] normalized to protein content (μg/μL). The inter- and intra-assay CVs were 8% and 6%, respectively.

Western blot for IL-6 protein
-----------------------------

HUVECs were washed twice in ice-cold Hanks buffered saline solution and lysed in Radio-Immunoprecipitation Assay Buffer with Roche protease inhibitor (RIPA-Pi). Phenylmethylsulfonyl fluoride protease inhibitor was also added to the RIPA-Pi to eliminate interference. At confluence, cells were collected, centrifuged at 16,000*g* for 10 minutes at 4°C. Quantification of protein content was measured by Bradford assay. 20 μg of protein was separated by electrophoresis through 10% SDS-polyacrylamide gel. Proteins were then transferred to nitrocellulose filter membranes. Membranes were blocked with non-fat dry milk in Tris-buffered saline and incubated overnight with primary antibodies at 4°C. Subsequently, the membranes were washed and then incubated with secondary antibody conjugated with horseradish peroxidase. Immunoreactive proteins were detected by chemiluminescence with Thermo Scientific SuperSignal substrate systems (Pierce Biotechnology). Anti-IL-6 (Abcam, Inc, MA). Actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used as the internal control. Band densitometry analysis was performed using National Institutes of Health ImageJ software.

Assay for superoxide dismutase (SOD) activity
---------------------------------------------

Total SOD activity was measured in order to have an assessment of the cell's potential for superoxide quenching. Total SOD activity in cell lysate samples by assay (Cayman Chemical, Ann Arbor, MI), as previously reported.[@b42-vhrm-7-541] Concentrations were normalized to protein content (μg/μL). Inter-assay and intra-assay CVs were 5.9% and 12.4%, respectively.

Assay for IL-6
--------------

IL-6 proteins released into media were measured in cell culture supernatants by ELISA (Thermo Scientific-Pierce Biotechnology, Rockford, IL), according to manufacturer's instructions. Concentrations were normalized to protein content (μg/μL). The intra- and inter-assay CVs were 9% and 10%, respectively.

Statistical analysis
--------------------

All values were presented as means ± SE. Two-way (ethnicity by condition) and one-way (within ethnicity and within experimental condition) ANOVA followed by Fisher's protected least significant difference (PLSD) were performed for statistical comparisons. An independent *t*-test was used to compare band densities for IL-6 expression between AA and Caucasian HUVECs. A *P*-value \<0.05 was considered statistically significant.

Results
=======

HUVEC morphology under all experimental conditions
--------------------------------------------------

Representative images of AA and Caucasian HUVECs at confluency under all experimental conditions are shown in [Figure 1](#f1-vhrm-7-541){ref-type="fig"}. HUVECs displayed a cobblestone-like shape. There were no morphological differences between the AA and Caucasian HUVECs.

EMP levels under basal conditions
---------------------------------

[Figure 2](#f2-vhrm-7-541){ref-type="fig"} shows comparisons of EMP levels between AA and Caucasian HUVECs under all experimental conditions. There were no significant differences in EMP levels under basal conditions between AA (3.6% ± 0.7%) and Caucasian (4.4% ± 0.6%) HUVECs (*P* = 0.38).

Effects of TNF-α stimulation and SOD on EMP generation
------------------------------------------------------

TNF-α is a potent inducer of inflammatory reactions and oxidative stress in EC. When the levels of EMPs were analyzed by experimental condition (AA and Caucasian HUVEC responses combined), TNF-α significantly increased EMP from the basal level of 3.9% ± 0.4% to 5.7% ± 0.6% (*P* = 0.01). Compared to the basal EMP level, SOD decreased the EMP level to 3.0% ± 0.5% (*P* = 0.19). Compared to the TNF-α condition, the addition of SOD significantly reduced the EMP level to 3.0 ± 0.3 (*P* \< 0.0001). The EMP levels under the SOD only condition (3.0 ± 0.3) and the TNF-α + SOD condition (2.6 ± 0.3) were not different.

The interactive effect of HUVEC race and experimental condition was borderline significant (*P* = 0.06, [Figure 2](#f2-vhrm-7-541){ref-type="fig"}). Post hoc analyses showed that AA HUVECs had a significantly greater level of EMP under the TNF-α condition compared to the Caucasian HUVECs (6.8 ± 1.1 vs 4.7% ± 0.4%, *P* = 0.04). Within the AA HUVECs, the EMP level increased by 89% from a basal level of 3.5 ± 0.7 to 6.8% ± 1.1% under the TNF-α condition (*P* = 0.01) ([Figure 3A](#f3-vhrm-7-541){ref-type="fig"}). Compared to the EMP level under the TNF-α condition, the EMP level was significantly lower under the SOD only condition (2.9% ± 0.3%, *P* = 0.005) and under the TNF-α + SOD condition (2.1% ± 0.4%, *P* = 0.001). Within the Caucasian HUVECs, there was only an 8% increase in the EMP level from the basal condition to the TNF-α condition (*P* = 0.70) ([Figure 3B](#f3-vhrm-7-541){ref-type="fig"}). The only significant difference in EMP levels in the Caucasian HUVECs was between the TNF-α (4.7% ± 0.4%) and the TNF-α + SOD condition (3.0% ± 0.3%, *P* = 0.02). The difference in the level of EMP between the TNF-α condition (4.7 ± 0.4) and the SOD condition (3.2 ± 1.0) was borderline significant (*P* = 0.05).

Total SOD activity under basal and TNF-α conditions
---------------------------------------------------

Total SOD activity in AA and Caucasian HUVECs under basal and TNF-α conditions are shown in [Figure 4](#f4-vhrm-7-541){ref-type="fig"}. Basal SOD activity levels were (17.2 ± 12.0 U/mg) in the AA HUVECs and (35.8 ± 17.2 U/mg) the Caucasian HUVECs (*P* = 0.03). Compared to the basal levels, TNF-α stimulation caused a significant increase in SOD activity in the AA HUVECs (*P* = 0.04), while no significant change occurred with TNF-α stimulation in Caucasian HUVECs (*P* = 0.09).

IL-6 concentrations under basal conditions
------------------------------------------

IL-6 concentrations in AA and Caucasian HUVECs under all experimental conditions are shown in [Figure 5](#f5-vhrm-7-541){ref-type="fig"}. Basal IL-6 concentrations were (56.1 ± 8.8 pg/mL/μg) in the AA HUVECs and (30.9 ± 14.9 pg/mL/μg) the Caucasian HUVECs (*P* = 0.17). Given the nearly two-fold higher basal IL-6 concentration in the AA HUVECs, we wanted to confirm whether IL-6 protein expression was greater. Representative Western blots for IL-6 protein under basal conditions are shown in [Figure 5](#f5-vhrm-7-541){ref-type="fig"}. Basal IL-6 protein expression was significantly greater in the AA HUVECs compared to the Caucasian HUVECs. This confirmed the greater basal IL-6 concentrations in the culture media of AA HUVECs.

Effects of TNF-α stimulation and SOD on IL-6 concentrations and protein expression
----------------------------------------------------------------------------------

The binding of TNF-α to its receptor on EC induces down-stream gene expression of IL-6, which can influence EC function and cause increased adhesion and chemokine expression and apoptosis. When the levels of IL-6 were analyzed by experimental condition (AA and Caucasian HUVEC responses combined), IL-6 concentration increased from 44.9 ± 8.8 pg/mL/μg protein under basal conditions to 62.6 ± 10.6 pg/mL/μg protein under TNF-α stimulation, but the difference was not statistically significant (*P* = 0.14). There were no significant differences in IL-6 concentrations between any of the other conditions. The interactive effect of HUVEC race and condition was not statistically significant (*P* = 0.43) ([Figure 5](#f5-vhrm-7-541){ref-type="fig"}). Within the AA HUVECs, the IL-6 concentration under the SOD condition tended to lower compared to the TNF-α condition (40.0 ± 8.0 vs 70.8 ± 15.7 pg/mL/μg, *P* = 0.07) ([Figure 5](#f5-vhrm-7-541){ref-type="fig"}). Within the Caucasian HUVECs, there were no significant differences in IL-6 concentrations between any of the experimental conditions ([Figure 4](#f4-vhrm-7-541){ref-type="fig"}).

Discussion
==========

The most important finding of this preliminary observational study was that for the first time we showed that TNF-α-stimulated EMP generation was different between African American and Caucasian HUVECs. AA HUVECs demonstrated an 89% increase in EMP generation as a result of TNF-α stimulation compared to an 8% increase in EMP generation in the Caucasian HUVECS. This finding is important because it is generally thought that for any given level of BP, African Americans have a greater degree of endothelial dysfunction compared to Caucasians and because the measurement of the EMP expression of marker CD31 is linked to EC activation/apoptosis. Therefore, these observations suggest that AA HUVECs have greater EC damage from TNF-α stimulation.

Microparticles are not released randomly into the circulation. [@b43-vhrm-7-541] Activation or injury of the endothelium leads to various inflammatory-related processes including the release of microparticles. Combes et al were the first to demonstrate that HUVECs release EMP when stimulated with TNF-α.[@b24-vhrm-7-541] Other proinflammatory, prothrombotic, proapoptotic, or oxidative substances also induce the release of EMP.[@b28-vhrm-7-541],[@b44-vhrm-7-541] EMP express adhesion molecules specific for mature ECs such as CD54 (ICAM-1), CD62E (E-selectin), CD62P (P-selectin), or CD31 (PECAM).[@b28-vhrm-7-541],[@b29-vhrm-7-541] CD31 is also expressed by platelet-derived microparticles, therefore EMP specificity is ensured by the CD31+/CD41− phenotype with CD41 being the platelet integrin GPIIbIIIa.[@b28-vhrm-7-541],[@b29-vhrm-7-541] Studies have demonstrated that EMP can be used as a novel biomarker of endothelial injury that directly reflects the homeostatic state of the endothelium.[@b29-vhrm-7-541],[@b45-vhrm-7-541]--[@b49-vhrm-7-541] To our knowledge, no study has used EMPs as an index of endothelial cell status to assess potential racial differences in EC function.

TNF-α stimulation caused a significant 89% increase in EMP level in AA HUVECs and a nonsignificant 8% increase in EMP level in the Caucasian HUVECs. The EMP levels under TNF-α stimulation were significantly different between the HUVEC groups. Based on these results, it appears that AA HUVECs were more susceptible to the damaging effects of TNF-α. Plasma TNF-α concentrations have been associated with early atherosclerosis.[@b50-vhrm-7-541] Moreover, there are reports that African Americans have higher systemic levels of inflammatory biomarkers[@b16-vhrm-7-541]--[@b21-vhrm-7-541] which suggests that at least a portion of their endothelial dysfunction may be secondary to cytokine-induced endothelial activation/ apoptosis.

The endothelium has several important functions related to cardiovascular health. Functional changes of the activated endothelium include disturbance of the regulation of vessel tone and the maintenance of a vascular environment that favors coagulation, inflammation, and atherosclerosis. EMP levels are increased in hypertension and a significant correlation was shown between EMP and blood pressure.[@b46-vhrm-7-541] It is thought that African Americans have lower endothelial NO bioavailability than Caucasians based on findings of attenuated flow-mediated arterial vasodilatation.[@b4-vhrm-7-541]--[@b6-vhrm-7-541] Other investigations have also documented lower endothelial-dependent vasodilation in African Americans.[@b8-vhrm-7-541]--[@b11-vhrm-7-541],[@b51-vhrm-7-541],[@b52-vhrm-7-541]

TNF-α can induce endothelial dysfunction through both inflammatory and oxidative stress mechanisms. TNF-α activates the p38 MAPK pathway[@b53-vhrm-7-541] and the transcription factor, NF-κB, which regulates the expression of genes involved in inflammation, oxidative stress, and endothelial dysfunction.[@b54-vhrm-7-541]--[@b56-vhrm-7-541] Inflammatory cytokines induce the expression of adhesion molecules and chemoattractants by ECs. Gertzberg et al and Yamagishi et al showed that in response to TNF-α, EC NADPH oxidase activity increased, leading to increased O~2~^−^ production.[@b57-vhrm-7-541],[@b58-vhrm-7-541] Under normal physiological conditions, the dismutation of O~2~^−^ by SOD yields H~2~O~2~. In the case of heightened NADPH oxidase activity and O~2~^−^ overproduction, O~2~^−^ reacts with NO to produce ONOO^−^ thus reducing NO bioavailability.[@b59-vhrm-7-541] In order to assess the potential for O~2~^−^ dismutation in the present study, total SOD activity was measured in cell lysate from both basal and TNF-α stimulated AA and Caucasian HUVECs. We observed significantly higher SOD activity in the Caucasian HUVECs under both conditions. The AA HUVECs had a 79% increase in SOD activity compared to a 50% increase in Caucasian HUVECs. This could suggest a higher oxidative stress response to the TNF-α stimulation which is also evidenced by the heightened EMP production with TNF-α stimulation in the African American HUVECs.

In the present study, we also measured EMP levels after incubation of the HUVECs with SOD alone and after incubation with TNF-α + SOD. The response to SOD alone was similar in both groups of HUVECs. Though both the AA and Caucasian HUVECs showed a significant decrease in EMP levels when the TNF-α + SOD condition was compared to the TNF-α alone condition, the AA HUVECs showed a 68% decrease in EMP levels whereas the Caucasian HUVECs showed a 35% decrease in EMP level. These results suggest that TNF-α-induced oxidative stress played a greater role in EMP generation in AA compared to Caucasian HUVECs because the effect of SOD was nearly twice that of the Caucasian HUVECs.

The proinflammatory cytokine TNF-α also induces EC gene expression and production of IL-6 via the NF-κB pathway. [@b58-vhrm-7-541] IL-6 is a secondary inflammatory cytokine that mediates the regulation of the acute-phase response to injury and infection. IL-6 induces the increase of plasma concentrations of fibrinogen, PAI-1, and CRP. Evidence indicates that the elevation of CRP predicts future cardiovascular events.[@b60-vhrm-7-541]

In the present study, we observed that the AA HUVECs had nearly a two-fold greater basal IL-6 concentration compared to the Caucasian HUVECs. Western blot analysis of basal IL-6 expression showed that the AA HUVECs had significantly greater IL-6 protein expression. The IL-6 response to SOD was also different between the HUVEC groups. SOD decreased IL-6 concentration in the AA HUVECs but increased IL-6 concentration in the Caucasian HUVECs. The reasons for the disparate IL-6 response to SOD are not clear. Incubating the HUVECs with TNF-α + SOD similarly decreased IL-6 concentrations compared to incubation with TNF-α alone. These changes were similar in both HUVEC groups. In healthy men, elevated levels of IL-6 were associated with increased future CVD risk, endothelial dysfunction, and hypertension.[@b61-vhrm-7-541]--[@b63-vhrm-7-541] Epidemiologic data support the existence of an association between different inflammatory markers and high blood pressure.[@b64-vhrm-7-541],[@b65-vhrm-7-541]

The normal functional integrity of ECs is maintained by continuous cell regeneration and the incorporation of endothelial progenitor cells. Under these normal quiescent conditions, EC activation tends to be localized, low-grade, and reversible. The level of circulating EMP is very low when ECs are quiescent.[@b66-vhrm-7-541] The exposure of the endothelium to cytokines causes vascular inflammation by inducing EC activation and apoptosis. There is a tendency for African Americans to have heightened systemic inflammation as measured by various inflammatory biomarkers.[@b16-vhrm-7-541]--[@b21-vhrm-7-541] Long-term exposure of the endothelium to proinflammatory cytokines leads to increased oxidative stress, inflammation, and apoptosis, and promotes leukocyte infiltration and thrombosis. All of these changes to ECs cause vascular dysfunction and support an EC environment favoring hypertension and atherosclerosis.

The aim of this observational study was to assess ECs that have not been exposed to chronic diseases in order to assess their fundamental response to stimuli. The HUVECs were purchased from Lonza Inc in which only the racial origin is known, due to The Health Insurance Portability and Accountability Act, which protects the privacy of individually identifiable health information. HUVECs are derived from fetal tissue which makes them better suited for measuring fundamental responses to stimuli because adult ECs may have been subjected to prolonged exposure to cytokines, hormones, and other stimuli, potentially resulting in an altered phenotype.[@b67-vhrm-7-541] An EC obtained from a newborn has already developed to the point where it is suitable for its particular function. One study found that out of the potentially confounding variables such as the interval between delivery and cell isolation, sex and weight of newborn, type of delivery, age, smoking habits, diabetes, or hypertension of the mother, only the short time between delivery and cell isolation and the mother's smoking habits lead to alterations in cell culture success rate[@b68-vhrm-7-541] and morphology.[@b69-vhrm-7-541] Thus while we do not know the specific characteristics of the mothers, we believe that the HUVECs were relatively unaffected by the mother.

There are several limitations of the study that are worth noting. First, we did not directly measure the levels of the superoxide radical. The measurement of total SOD activity provides insight into the cell's potential for superoxide quenching. Second, we only incubated the cells with TNF-α for 4 hours. This was done in order to avoid significant apoptosis. Lastly, the present observational study cannot provide insight into potential mechanisms for heightened EC susceptibility to TNF-α in AA HUVECs but it may lie in differences in TNF-α receptor sensitivity and/or post-receptor signaling mechanisms.

The preliminary results of our study suggest that AA HUVECs are more susceptible to the injurious effects of the proinflammatory cytokine, TNF-α. In addition, the results suggest that TNF-α-induced oxidative stress plays a greater role in EMP generation in AA compared to Caucasian HUVECs. If African Americans tend to have a subclinical heightened state of chronic systemic low-grade inflammation, then the manner in which their ECs respond to inflammatory cytokines could make them more susceptible to long-term endothelial dysfunction and its sequelae such as hypertension and atherosclerosis. This warrants the importance of aggressive preventive lifestyle modification strategies in African Americans in early subclinical stages of hypertension development to reduce the inflammation and oxidative stress burdens.
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![Representative images of African American and Caucasian HUVECs at harvest under all experimental conditions.\
**Abbreviations:** HUVEC, human umbilical vein endothelial cells; SOD, superoxide dismutase; TNF-α, tissue necrosis factor alpha.](vhrm-7-541f1){#f1-vhrm-7-541}

![Comparison of EMP levels between the African American and Caucasian HUVEC groups under each of the experimental conditions.\
**Note:** \**P* \< 0.05 between HUVEC racial groups.\
**Abbreviations:** HUVEC, human umbilical vein endothelial cells; SOD, superoxide dismutase, EMP, endothelial microparticles; ANOVA, analysis of variance.](vhrm-7-541f2){#f2-vhrm-7-541}

![**A**) EMP levels under each of the experimental conditions in African American HUVECs. **B**) EMP levels under each of the experimental conditions in Caucasian HUVECs.\
**Abbreviations:** HUVEC, human umbilical vein endothelial cells; SOD, superoxide dismutase, EMP, endothelial microparticles.](vhrm-7-541f3){#f3-vhrm-7-541}

![Total SOD activity under basal and TNF-α conditions in African American and Caucasian HUVECs.\
**Notes:** \**P* \< 0.05 between HUVEC racial groups within condition; ^†^*P* \< 0.05 compared to TNF-α condition within racial HUVEC groups.\
**Abbreviations:** HUVEC, human umbilical vein endothelial cells; SOD, superoxide dismutase; TNF-α, tissue necrosis factor alpha.](vhrm-7-541f4){#f4-vhrm-7-541}

![IL-6 concentrations under each of the experimental conditions in African American and Caucasian HUVECs.\
**Notes:** \**P* \< 0.05 between HUVEC racial groups within condition; ^†^*P* \< 0.05 compared to TNF-α condition within racial HUVEC groups. At the top are representative Western blots of basal IL-6 protein expression levels in African American and Caucasian basal HUVECs.\
**Abbreviations:** HUVEC, human umbilical vein endothelial cells; SOD, superoxide dismutase; TNF-α, tissue necrosis factor alpha; ANOVA, analysis of variance.](vhrm-7-541f5){#f5-vhrm-7-541}
